今日药学
今日藥學
금일약학
PHARMACY TODAY
2009年
7期
45-46
,共2页
弥可保%糖尿病%周围性神经病变
瀰可保%糖尿病%週圍性神經病變
미가보%당뇨병%주위성신경병변
Mecobalamin diabetic peripheral neuropathy
目的 观察弥可保对糖尿病周围神经病变的治疗效果.方法 把38例患者随机分为2组,对照组19例在血糖治疗基础上加上维生素B1治疗,治疗组19例在血糖治疗基础上加用弥可保治疗.结果 对照组明显改善10.5%,总有效率52.6%,同时治疗组明显改善42.1%,总有效率89.5%.两组间有显著性差异(P<0.05).结论 弥可保是治疗糖尿病周围神经病变的有效药物.
目的 觀察瀰可保對糖尿病週圍神經病變的治療效果.方法 把38例患者隨機分為2組,對照組19例在血糖治療基礎上加上維生素B1治療,治療組19例在血糖治療基礎上加用瀰可保治療.結果 對照組明顯改善10.5%,總有效率52.6%,同時治療組明顯改善42.1%,總有效率89.5%.兩組間有顯著性差異(P<0.05).結論 瀰可保是治療糖尿病週圍神經病變的有效藥物.
목적 관찰미가보대당뇨병주위신경병변적치료효과.방법 파38례환자수궤분위2조,대조조19례재혈당치료기출상가상유생소B1치료,치료조19례재혈당치료기출상가용미가보치료.결과 대조조명현개선10.5%,총유효솔52.6%,동시치료조명현개선42.1%,총유효솔89.5%.량조간유현저성차이(P<0.05).결론 미가보시치료당뇨병주위신경병변적유효약물.
Objective: To observe the effect of Mecobalamin on diabetic peripheral neuropathy. Methods 38 patientsare divided into two groups at random, one part is controlling group, another part is treatment group. Controlling group,19 cases in treatment based on blood glucose coupled with treatment of vitamin B1, treatment group, 19 cases in treatment based on blood glucose coupled with treatment of Mecobalamin. Results significant improvement in the control group is 10.5%, the total effective rate is 52.6%, while the treatment group improved 42.1%, the total effectiverate is 89.5%. Significant difference is between two group(P<0.05). Conclusion Mecobalamin is an effective drug for diabeticperipheral neuropathy.
